13.01
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Eyepoint Pharmaceuticals Inc Borsa (EYPT) Ultime notizie
How EyePoint Pharmaceuticals Inc. stock performs in high volatility marketsWall Street Watch & Fast Gaining Stock Strategy Reports - newser.com
EyePoint Announces Participation at Upcoming Investor Conferences - EyePoint Pharmaceuticals
EyePoint (NASDAQ: EYPT) to appear at Guggenheim, Stifel and Jefferies investor events - Stock Titan
Should you wait for a breakout in EyePoint Pharmaceuticals Inc.Market Sentiment Summary & Daily Profit Focused Screening - newser.com
Is EyePoint Pharmaceuticals Inc. stock ready for breakoutQuarterly Risk Review & Weekly Stock Breakout Alerts - newser.com
What’s next for EyePoint Pharmaceuticals Inc. stock priceTrade Volume Summary & Fast Entry High Yield Tips - newser.com
EyePoint Pharmaceuticals Inc. stock outlook for YEAROptions Play & Precise Trade Entry Recommendations - newser.com
Will EyePoint Pharmaceuticals Inc. (PV3B) stock deliver compounding returnsPortfolio Performance Summary & Long-Term Capital Growth Ideas - newser.com
Has EyePoint Pharmaceuticals Inc. formed a bullish divergenceJobs Report & Growth Oriented Trading Recommendations - newser.com
Will EyePoint Pharmaceuticals Inc. stock split attract more investorsBond Market & AI Powered Market Trend Analysis - newser.com
Is EyePoint Pharmaceuticals Inc. (PV3B) stock a buy before new product rollout - newser.com
Combining price and volume data for EyePoint Pharmaceuticals Inc.July 2025 Institutional & Fast Gain Stock Trading Tips - newser.com
EyePoint Pharmaceuticals (NASDAQ:EYPT) shareholder returns have been stellar, earning 212% in 5 years - simplywall.st
Eyepoint Pharmaceuticals (EYPT) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
EyePoint Pharmaceuticals Inc Stock Analysis and ForecastCandlestick Pattern Analysis & Consistently Superior Profits - earlytimes.in
With 57% institutional ownership, EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) is a favorite amongst the big guns - Yahoo Finance
Will EyePoint Pharmaceuticals Inc. stock outperform growth indexesTrade Risk Report & Free High Return Stock Watch Alerts - newser.com
EyePoint Pharmaceuticals to Host Conference Call for Q3 2025 Financial Results on November 5, 2025 - Quiver Quantitative
EyePoint to Report Third Quarter 2025 Financial Results on November 5, 2025 - The Manila Times
EyePoint Pharmaceuticals (NASDAQ: EYPT) sets 8:30 a.m. ET call to discuss Q3 results - Stock Titan
Will EyePoint Pharmaceuticals Inc. stock see insider buyingJuly 2025 Momentum & Weekly High Momentum Picks - fcp.pa.gov.br
Is EyePoint Pharmaceuticals Inc. stock recession proof2025 Risk Factors & Verified Short-Term Trading Plans - fcp.pa.gov.br
Is EyePoint Pharmaceuticals Inc. stock a safe buy before earningsWeekly Stock Recap & Smart Money Movement Tracker - fcp.pa.gov.br
EyePoint Pharmaceuticals Completes US$150 Million Follow-On Equity Offering - Global Legal Chronicle
What drives EyePoint Pharmaceuticals Inc stock priceDouble Top/Bottom Patterns & Maximize Gains Professionally - earlytimes.in
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):